-
Oct 01 |
Diagnostics World | We have entered a new era of science focused on developing tools and technologies to support early detection and diagnosis. The rapid evolution of research has led to the need to systematically collect, review, and distill findings into clear and actionable recommendations for how to use these tools in clinical practice
More
-
Sep 30 |
Diagnostics World | For patients with metastatic brain cancer, stereotactic radiosurgery has become an increasingly common treatment over the past decade based on the recommendations of medical physicists, guidelines of professional societies, and coverage guidelines of federal agencies. There has also been a change in the drugs used to treat the underlying cancer in conjunction with the procedure, especially in cases of metastatic cancer.
More
-
Sep 25 |
Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.
More
-
Sep 24 |
Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more.
More
-
Sep 18 |
Diagnostics World | Last week Apple introduced Apple Watch Series 11, offering the most comprehensive set of health features yet, longer battery life, an even more durable cover glass, and 5G cellular capabilities, all in its thinnest and most comfortable design. Among the new features, Apple Watch Series 11 introduced FDA-cleared hypertension notifications, which can alert users if signs of chronic high blood pressure — or hypertension — are detected.
More
-
Sep 17 |
Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers.
More
-
Sep 16 |
Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid.
More
-
Sep 11 |
Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.
More
-
Sep 09 |
Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.
More
-
Sep 04 |
Diagnostics World | In a lively matchup between clinical microbiology experts at the recent Next-Generation Dx Summit, onlookers already predisposed to believing artificial intelligence (AI) would not be replacing conventional microbiology and infectious disease testing in the next 10 years were further swayed toward dismissing the possibility. It perhaps helped that the deciding vote on the debate came immediately after the person arguing mightily about the inevitability of an AI takeover himself switched from the affirmative to the negative position.
More
-
Oct 03 |
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, is proud to be Certified™ by Great Place To Work®! The prestigious award is based entirely on what current employees say about their experience working at Baylor Genetics. This recognition is based entirely on feedback from current employees about their workplace experience. In 2025, Baylor Genetics employees rated the company 17 points higher than the average U.S. workplace.
More
-
Oct 01 |
More
-
Oct 01 |
More
-
Sep 30 |
Pathologists readily embrace the shift to digital workflows.
More
-
Sep 26 |
Baltimore, MD – Sept 22, 2025 – Scanogen Inc. has received a $2.9 million grant from the NIH/NIAID to scale its rapid diagnostic platform for life-threatening yeast bloodstream infections. Powered by proprietary SMART technology, the system delivers results directly from blood samples in hours—far faster than traditional blood cultures.
The funding will support FDA-compliant production, software upgrades, and preparation for clinical trials. CEO Dr. Al Celedon stated the grant is a major step toward faster diagnosis and improved patient survival.
More
-
Sep 26 |
ClearNote Health receives UKCA markings for both the Avantect Ovarian Test and the Avantect Multi-Cancer Detection Test.
More
-
Sep 25 |
Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder
More
-
Sep 25 |
More
-
Sep 24 |
Delivering a menu of H&E, IHC, and special stains on the Concentriq platform
More
-
Sep 22 |
Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners
More
View more articles